The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/12121
StudyName: Eligibility Neoadjuvant Operable Breast Cancer NCT02400567
Date of export from the portal: 02.07.2020
Date of Upload / last change: 25.09.2015
License: Creative Commons BY 4.0

----

Description: 
Efficacy of Letrozole + Palbociclib Combination as Neoadjuvant Treatment of Stage II-IIIA PAM 50 ROR-defined Low or Intermediate Risk Luminal Breast Cancer, in Postmenopausal Women; ODM derived from: https://clinicaltrials.gov/show/NCT02400567
